A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
INTERVENTION: Control group:Conventional treatment;Experimental group:Conventional treatment pius Dao Yin; CONDITION: Novel Coronavirus Pneumonia (COVID‐19) PRIMARY OUTCOME: Length of hospital stay; SECONDARY OUTCOME: Vital signs;Respiratory symptoms;mental health;immune cells; INCLUSION CRITERIA: 1. Aged 18 to 60 years old; 2. Inpatients who meet the diagnostic criteria for mild, general and neonatal pneumonia in western medicine, and early and recovery stages of traditional Chinese medicine; 3. Understand and agree to participate in this study and sign the informed consent.
Epistemonikos ID: 7ada2e010bb94e71eabda2d0714c9d1db2076b4d
First added on: Apr 14, 2020